The US Food and Drug Administration has approved a new drug to treat schizophrenia after over three decades. As stated in a Sept. 26 press release, the new oral drug, Cobenfy, is a twice-daily pill ...
Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is ...